Related references
Note: Only part of the references are listed.Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer
Andreas Herbst et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Colon Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Bridging the translational innovation gap through good biomarker practice
Alain J. van Gool et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer
Tao He et al.
EPIGENOMICS (2017)
Details matter: the role of genomic location and assay standardization in DNA methylation analyses
Guro E. Lind et al.
EPIGENOMICS (2017)
Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer
R. Kandimalla et al.
ONCOGENESIS (2017)
Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review
Gaowei Fan et al.
PLOS ONE (2017)
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
Peggy Sekula et al.
PLOS ONE (2017)
Waste, Leaks, and Failures in the Biomarker Pipeline
John P. A. Ioannidis et al.
CLINICAL CHEMISTRY (2017)
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
Rodrigo Dienstmann et al.
NATURE REVIEWS CANCER (2017)
IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers
Tao Fu et al.
ANNALS OF SURGERY (2016)
Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer
Xiao-Chun Kang et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Methylation of CDX2 as a Predictor in Poor Clinical Outcome of Patients with Colorectal Cancer
Guozhong Jiang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2016)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances
Gustaw Lech et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer
Dimitrios Matthaios et al.
ONCOLOGY LETTERS (2016)
Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer
Xiang Luo et al.
SCIENTIFIC REPORTS (2016)
Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review
Min Jia et al.
CLINICAL EPIGENETICS (2016)
Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome
Muriel X. G. Draht et al.
CLINICAL EPIGENETICS (2016)
Tracking the Correlation Between CpG Island Methylator Phenotype and Other Molecular Features and Clinicopathological Features in Human Colorectal Cancers: A Systematic Review and Meta-Analysis
Liang Zong et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Experimental factors affecting the robustness of DNA methylation analysis
Heidi D. Pharo et al.
SCIENTIFIC REPORTS (2016)
DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis
Ming-Hong Tsai et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Improving the Quality of Biomarker Discovery Research: The Right Samples and Enough of Them
Margaret S. Pepe et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Yoshinaga Okugawa et al.
GASTROENTEROLOGY (2015)
Fibulin-1 Is Downregulated Through Promoter Hypermethylation in Colorectal Cancer A Consort Study
Zhiying Xu et al.
MEDICINE (2015)
Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumors
S. Veganzones et al.
TUMOR BIOLOGY (2015)
A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer
Pei-Ching Lin et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
The national biomarker development alliance: confronting the poor productivity of biomarker research and development
George Poste et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer
S. Wang et al.
ONCOGENE (2015)
TFAP2E Methylation Status and Prognosis of Patients with Radically Resected Colorectal Cancer
Seong Joan Park et al.
ONCOLOGY (2015)
DNA Methylation Combinations in Adjacent Normal Colon Tissue Predict Cancer Recurrence: Evidence from a Clinical Cohort Study
Jen Chun Kuan et al.
PLOS ONE (2015)
Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer
Shasha Su et al.
PLOS ONE (2015)
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2014)
Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis
Y. Y. Juo et al.
ANNALS OF ONCOLOGY (2014)
DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence
Anne Benard et al.
APOPTOSIS (2014)
Expression of BMP6 is Associated with its Methylation Status in Colorectal Cancer Tissue but Lacks Prognostic Significance
Patcharaporn Sangplod et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Biological significance of the CpG island methylator phenotype
Hiromu Suzuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
The National Biomarker Development Alliance accelerating the translation of biomarkers to the clinic
Anna D. Barker et al.
BIOMARKERS IN MEDICINE (2014)
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
Jaime Antonio Oliver et al.
BMC CANCER (2014)
Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
Alexander B. Philipp et al.
BMC CANCER (2014)
Postoperative Serum Methylation Levels of TAC1 and SEPT9 Are Independent Predictors of Recurrence and Survival of Patients with Colorectal Cancer
CheeKian Tham et al.
CANCER (2014)
Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation
Fabio Coppede
CANCER LETTERS (2014)
CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer
Arjen H. G. Cleven et al.
CLINICAL CANCER RESEARCH (2014)
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
Timothy Robert Church et al.
GUT (2014)
KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer
Maija R. J. Kohonen-Corish et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer
Zuo-Ming Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1
Ellen Heitzer et al.
MODERN PATHOLOGY (2014)
Prognostic Potential of DNA Methylation and Transcript Levels of HIF1A and EPAS1 in Colorectal Cancer
Agnieszka Anna Rawluszko-Wieczorek et al.
MOLECULAR CANCER RESEARCH (2014)
Increasing value and reducing waste in research design, conduct, and analysis
John P. A. Ioannidis et al.
LANCET (2014)
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
Muriel X. G. Draht et al.
MOLECULAR ONCOLOGY (2014)
Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancer
Yibaina Wang et al.
MEDICAL ONCOLOGY (2014)
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Thomas F. Imperiale et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer
Lucia Perez-Carbonell et al.
PLOS ONE (2014)
Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India
Pooja Malhotra et al.
TUMOR BIOLOGY (2014)
Biological significance of promoter hypermethylation of p14/ARF gene: Relationships to p53 mutational status in Tunisian population with colorectal carcinoma
Ines Chaar et al.
TUMOR BIOLOGY (2014)
Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance
Rania Abdelmaksoud-Dammak et al.
TUMOR BIOLOGY (2014)
The specific methylation characteristics of cancer related genes in Chinese colorectal cancer patients
WenJie Yang et al.
TUMOR BIOLOGY (2014)
Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer
Jochen Gaedcke et al.
ONCOTARGET (2014)
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review
Adrienne Stevens et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Tracking the Molecular Features of Nonpolypoid Colorectal Neoplasms: A Systematic Review and Meta-Analysis
Quirinus J. M. Voorham et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Biomarker Failures
John P. A. Ioannidis
CLINICAL CHEMISTRY (2013)
DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients
Torbjorn K. Nilsson et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
Anguraj Sadanandam et al.
NATURE MEDICINE (2013)
Hypermethylation and prognostic implication of Syk gene in human colorectal cancer
Zuli Yang et al.
MEDICAL ONCOLOGY (2013)
KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer
Patricia Moya et al.
TUMOR BIOLOGY (2013)
Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study
Lars Henrik Jensen et al.
CELLULAR ONCOLOGY (2013)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
H. J. Schmoll et al.
ANNALS OF ONCOLOGY (2012)
Methylation of the Polycomb Group Target Genes Is a Possible Biomarker for Favorable Prognosis in Colorectal Cancer
Ashraf Dallol et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications
Frank A. Sinicrope et al.
CLINICAL CANCER RESEARCH (2012)
β-Catenin and K-Ras Mutations and RASSF1A Promoter Methylation in Taiwanese Colorectal Cancer Patients
Shee-Ping Chen et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
Risk prediction models: II. External validation, model updating, and impact assessment
Karel G. M. Moons et al.
HEART (2012)
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker
Karel G. M. Moons et al.
HEART (2012)
Prognostic role of methylated free circulating DNA in colorectal cancer
Alexander B. Philipp et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing
Michel P. Bihl et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
CDH13 and FLBN3 Gene Methylation are Associated with Poor Prognosis in Colorectal Cancer
Zhu Wang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Diagnostic and prognostic utility of methylation and protein expression patterns of myopodin in colon cancer
Sergio Esteban et al.
TUMOR BIOLOGY (2012)
PIK3CA mutation and methylation influences the outcome of colorectal cancer
Satoru Iida et al.
ONCOLOGY LETTERS (2012)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Douglas G. Altman et al.
PLOS MEDICINE (2012)
Epigenetic Silencing of HOPX Promotes Cancer Progression in Colorectal Cancer
Hiroshi Katoh et al.
NEOPLASIA (2012)
Aberrant methylation of hMLH1 and p16INK4a in Tunisian patients with sporadic colorectal adenocarcinoma
Imen Miladi-Abdennadher et al.
BIOSCIENCE REPORTS (2011)
DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer
T. Cui et al.
BRITISH JOURNAL OF CANCER (2011)
Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients
J. B. Rawson et al.
BRITISH JOURNAL OF CANCER (2011)
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers
Kaori Shima et al.
CANCER CAUSES & CONTROL (2011)
Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients
Felipe de Sousa e Melo et al.
CELL STEM CELL (2011)
Association of CHFR Promoter Methylation with Disease Recurrence in Locally Advanced Colon Cancer
Motofumi Tanaka et al.
CLINICAL CANCER RESEARCH (2011)
Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location!
Iris J. H. van Vlodrop et al.
CLINICAL CANCER RESEARCH (2011)
Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer
Joo Mi Yi et al.
CLINICAL CANCER RESEARCH (2011)
Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: cohort study and literature review
Kaori Shima et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
John P. A. Ioannidis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
TWIST1 Promoter Methylation in Primary Colorectal Carcinoma
Rubia D. Ruppenthal et al.
PATHOLOGY & ONCOLOGY RESEARCH (2011)
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
S. Mallett et al.
BRITISH JOURNAL OF CANCER (2010)
DNA methylation markers in colorectal cancer
Myoung Sook Kim et al.
CANCER AND METASTASIS REVIEWS (2010)
Hypomethylation of the IGF2 DMR in Colorectal Tumors, Detected by Bisulfite Pyrosequencing, Is Associated With Poor Prognosis
Yoshifumi Baba et al.
GASTROENTEROLOGY (2010)
Microsatellite Instability in Colorectal Cancer
C. Richard Boland et al.
GASTROENTEROLOGY (2010)
Aberrant p16INK4a methylation is a frequent event in colorectal cancers: prognostic value and relation to mRNA expression and immunoreactivity
Hiroyuki Mitomi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Untitled
Yvonne Wettergren et al.
MOLECULAR MEDICINE (2010)
Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer
J. Yu et al.
ONCOGENE (2010)
Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome
Massimo Pancione et al.
PLOS ONE (2010)
Reporting bias in medical research - a narrative review
Natalie McGauran et al.
TRIALS (2010)
Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma
Imen Miladi-Abdennadher et al.
TUMOR BIOLOGY (2010)
Methylated BNIP3 gene in colorectal cancer prognosis
Sayaka Shimizu et al.
ONCOLOGY LETTERS (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Aberrant promoter methylation of p16 in colorectal adenocarcinoma in North Indian patients
Pooja Malhotra et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence
Andreas Herbst et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
The Association of Methylation in the Promoter of APC and MGMT and the Prognosis of Taiwanese CRC Patients
Shee-Ping Chen et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2009)
Heterogeneity and Power in Clinical Biomarker Studies
Melania Pintilie et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Promoter Hypermethylation of Tumor-Related Genes in Peritoneal Lavage and the Prognosis of Patients With Colorectal Cancer
Hidenori Kamiyama et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Colon Cancer
Paul F. Engstrom et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
Fatima Haggar et al.
Clinics in Colon and Rectal Surgery (2009)
Prognosis and prognostic research: what, why, and how?
Karel G. M. Moons et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer
Yvonne Wettergren et al.
MOLECULAR MEDICINE (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Almost all articles on cancer prognostic markers report statistically significant results
Panayiotis A. Kyzas et al.
EUROPEAN JOURNAL OF CANCER (2007)
Comethylation of p16 and MGMT genes in colorectal carcinoma:: Correlation with clinicopathological features and prognostic value
Koviljka Krtolica et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Methylation of serum DNA is an independent prognostic marker in colorectal cancer
Maike Wallner et al.
CLINICAL CANCER RESEARCH (2006)
Influence of methylated p15INK4b and p16INK4a genes on clinicopathological features in colorectal cancer
Atsushi Ishiguro et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
p16 gene methylation in colorectal tumors: Correlation with clinicopathological features and prognostic value
MT Sans-Casla et al.
DIGESTIVE DISEASES (2005)
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines
A Burton et al.
BRITISH JOURNAL OF CANCER (2004)
Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis
N Umetani et al.
CLINICAL CANCER RESEARCH (2004)
The power and the promise of DNA methylation markers
PW Laird
NATURE REVIEWS CANCER (2003)
Colorectal carcinoma: Diagnostic, prognostic, and molecular features
CC Compton
MODERN PATHOLOGY (2003)
Challenges and opportunities in evaluating diagnostic tests
DF Ransohoff
JOURNAL OF CLINICAL EPIDEMIOLOGY (2002)
Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability
M Hermsen et al.
GASTROENTEROLOGY (2002)
K-ras and p16 aberrations confer poor prognosis in human colorectal cancer
M Esteller et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
